Therapeutic Potency of Mono and Diprenylated Acetophenone: A Case Study of in-vivo Antimalarial Evaluation

28 April 2022, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Malaria remains a febrile infection of public health concern in many countries especially tropical countries in Africa, and certain countries in Southern and North America such as Brazil, Costa Rica, Mexico, Dominican Republic, Colombia, and Ecuador. Hence this has made research into this area paramount. Acetophenones are active fragments in many compounds with promising antimalarial activity, such as chalcones. In this study, 3,5-diprenyl acetophenone (I) and 5-diprenyl (II) acetophenone were synthesized using an aromatic substitution reaction and tested for in-vivo antimalarial activity. The in-vivo antimalarial potential of the synthesized compounds was carried out using a curative model with plasmodium berghei infected mice. At all the three doses tested; 25 mgkg-1, 50 mgkg-1 and 100 mgkg-1 3,5-diprenyl acetophenone (I) showed promising activity with percentage inhibition of 68.03%, 65.16% and 69.75% respectively demonstrating dose-dependent activity. However, 5-prenyl acetophenone (II) only displayed significant activity (72.12% inhibition) at a dose of 100 mgkg-1. The two compounds passed Lipinski’s rule of five and thus drug-like candidates.

Keywords

Malaria
prenylated acetophenone
3-prenyl acetophenone
Fragment-based drug discovery.
3
5-diprenyl acetophenone

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.